Cholesterol-modified prognostic nutritional index as an independent prognostic biomarker in primary biliary cholangitis patients
Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease characterized by inflammation of the interlobular bile ducts, often associated with malabsorption of fat-soluble vitamins and osteoporosis. Thus, evaluating the nutritional status of patients with PBC and implementing appropria...
Saved in:
Published in | BMC gastroenterology Vol. 25; no. 1; pp. 421 - 9 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
30.05.2025
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease characterized by inflammation of the interlobular bile ducts, often associated with malabsorption of fat-soluble vitamins and osteoporosis. Thus, evaluating the nutritional status of patients with PBC and implementing appropriate interventions are significant. But CPNI in determining the nutritional status and forecasting survival outcome among patients with PBC remains unclear.
A total of 262 patients with PBC were retrospectively enrolled at the Second Affiliated Hospital of Kunming Medical University between January 2013 and November 2023. We used the receiver operating characteristic (ROC) curve, Kaplan-Meier survival curve, and logistic regression analysis to evaluate the predictive effects of several nutritional assessments. These assessments included the controlling nutritional status (CONUT), geriatric nutritional risk index (GNRI), prognostic nutritional index (PNI), and Cholesterol-modified Prognostic Nutritional Index (CPNI), which were evaluated for their predictive effect on the prognosis of PBC patients.
In our study, after adjusting for various confounding factors, multivariate cox regression analyses revealed that CPNI (HR: 1.114, 95% CI: 1.003-1.237, P = 0.044), age (HR: 1.071, 95% CI: 1.018-1.127, P < 0.009), total bilirubin (HR:1.019, 95% CI:1.009-1.09, P < 0.001) were independent risk factors for death in patients with PBC. The Kaplan-Meier curves and ROC curves used to assess predictive accuracy showed that CPNI(0.788) had superior prognostic performance for OS compared to other nutritional indices, such as CONUT(0.724), GNRI(0.755), PNI(0.776), and UK-PBC(0.660)(P < 0.05).
CPNI is superior to other nutritional scores in the prognostic assessment of PBC patients. |
---|---|
AbstractList | Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease characterized by inflammation of the interlobular bile ducts, often associated with malabsorption of fat-soluble vitamins and osteoporosis. Thus, evaluating the nutritional status of patients with PBC and implementing appropriate interventions are significant. But CPNI in determining the nutritional status and forecasting survival outcome among patients with PBC remains unclear.BACKGROUNDPrimary biliary cholangitis (PBC) is a chronic cholestatic liver disease characterized by inflammation of the interlobular bile ducts, often associated with malabsorption of fat-soluble vitamins and osteoporosis. Thus, evaluating the nutritional status of patients with PBC and implementing appropriate interventions are significant. But CPNI in determining the nutritional status and forecasting survival outcome among patients with PBC remains unclear.A total of 262 patients with PBC were retrospectively enrolled at the Second Affiliated Hospital of Kunming Medical University between January 2013 and November 2023. We used the receiver operating characteristic (ROC) curve, Kaplan-Meier survival curve, and logistic regression analysis to evaluate the predictive effects of several nutritional assessments. These assessments included the controlling nutritional status (CONUT), geriatric nutritional risk index (GNRI), prognostic nutritional index (PNI), and Cholesterol-modified Prognostic Nutritional Index (CPNI), which were evaluated for their predictive effect on the prognosis of PBC patients.METHODSA total of 262 patients with PBC were retrospectively enrolled at the Second Affiliated Hospital of Kunming Medical University between January 2013 and November 2023. We used the receiver operating characteristic (ROC) curve, Kaplan-Meier survival curve, and logistic regression analysis to evaluate the predictive effects of several nutritional assessments. These assessments included the controlling nutritional status (CONUT), geriatric nutritional risk index (GNRI), prognostic nutritional index (PNI), and Cholesterol-modified Prognostic Nutritional Index (CPNI), which were evaluated for their predictive effect on the prognosis of PBC patients.In our study, after adjusting for various confounding factors, multivariate cox regression analyses revealed that CPNI (HR: 1.114, 95% CI: 1.003-1.237, P = 0.044), age (HR: 1.071, 95% CI: 1.018-1.127, P < 0.009), total bilirubin (HR:1.019, 95% CI:1.009-1.09, P < 0.001) were independent risk factors for death in patients with PBC. The Kaplan-Meier curves and ROC curves used to assess predictive accuracy showed that CPNI(0.788) had superior prognostic performance for OS compared to other nutritional indices, such as CONUT(0.724), GNRI(0.755), PNI(0.776), and UK-PBC(0.660)(P < 0.05).RESULTSIn our study, after adjusting for various confounding factors, multivariate cox regression analyses revealed that CPNI (HR: 1.114, 95% CI: 1.003-1.237, P = 0.044), age (HR: 1.071, 95% CI: 1.018-1.127, P < 0.009), total bilirubin (HR:1.019, 95% CI:1.009-1.09, P < 0.001) were independent risk factors for death in patients with PBC. The Kaplan-Meier curves and ROC curves used to assess predictive accuracy showed that CPNI(0.788) had superior prognostic performance for OS compared to other nutritional indices, such as CONUT(0.724), GNRI(0.755), PNI(0.776), and UK-PBC(0.660)(P < 0.05).CPNI is superior to other nutritional scores in the prognostic assessment of PBC patients.CONCLUSIONSCPNI is superior to other nutritional scores in the prognostic assessment of PBC patients. BackgroundPrimary biliary cholangitis (PBC) is a chronic cholestatic liver disease characterized by inflammation of the interlobular bile ducts, often associated with malabsorption of fat-soluble vitamins and osteoporosis. Thus, evaluating the nutritional status of patients with PBC and implementing appropriate interventions are significant. But CPNI in determining the nutritional status and forecasting survival outcome among patients with PBC remains unclear.MethodsA total of 262 patients with PBC were retrospectively enrolled at the Second Affiliated Hospital of Kunming Medical University between January 2013 and November 2023. We used the receiver operating characteristic (ROC) curve, Kaplan–Meier survival curve, and logistic regression analysis to evaluate the predictive effects of several nutritional assessments. These assessments included the controlling nutritional status (CONUT), geriatric nutritional risk index (GNRI), prognostic nutritional index (PNI), and Cholesterol-modified Prognostic Nutritional Index (CPNI), which were evaluated for their predictive effect on the prognosis of PBC patients.ResultsIn our study, after adjusting for various confounding factors, multivariate cox regression analyses revealed that CPNI (HR: 1.114, 95% CI: 1.003–1.237, P = 0.044), age (HR: 1.071, 95% CI: 1.018–1.127, P < 0.009), total bilirubin (HR:1.019, 95% CI:1.009–1.09, P < 0.001) were independent risk factors for death in patients with PBC. The Kaplan–Meier curves and ROC curves used to assess predictive accuracy showed that CPNI(0.788) had superior prognostic performance for OS compared to other nutritional indices, such as CONUT(0.724), GNRI(0.755), PNI(0.776), and UK-PBC(0.660)(P < 0.05).ConclusionsCPNI is superior to other nutritional scores in the prognostic assessment of PBC patients. Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease characterized by inflammation of the interlobular bile ducts, often associated with malabsorption of fat-soluble vitamins and osteoporosis. Thus, evaluating the nutritional status of patients with PBC and implementing appropriate interventions are significant. But CPNI in determining the nutritional status and forecasting survival outcome among patients with PBC remains unclear. A total of 262 patients with PBC were retrospectively enrolled at the Second Affiliated Hospital of Kunming Medical University between January 2013 and November 2023. We used the receiver operating characteristic (ROC) curve, Kaplan-Meier survival curve, and logistic regression analysis to evaluate the predictive effects of several nutritional assessments. These assessments included the controlling nutritional status (CONUT), geriatric nutritional risk index (GNRI), prognostic nutritional index (PNI), and Cholesterol-modified Prognostic Nutritional Index (CPNI), which were evaluated for their predictive effect on the prognosis of PBC patients. In our study, after adjusting for various confounding factors, multivariate cox regression analyses revealed that CPNI (HR: 1.114, 95% CI: 1.003-1.237, P = 0.044), age (HR: 1.071, 95% CI: 1.018-1.127, P < 0.009), total bilirubin (HR:1.019, 95% CI:1.009-1.09, P < 0.001) were independent risk factors for death in patients with PBC. The Kaplan-Meier curves and ROC curves used to assess predictive accuracy showed that CPNI(0.788) had superior prognostic performance for OS compared to other nutritional indices, such as CONUT(0.724), GNRI(0.755), PNI(0.776), and UK-PBC(0.660)(P < 0.05). CPNI is superior to other nutritional scores in the prognostic assessment of PBC patients. Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease characterized by inflammation of the interlobular bile ducts, often associated with malabsorption of fat-soluble vitamins and osteoporosis. Thus, evaluating the nutritional status of patients with PBC and implementing appropriate interventions are significant. But CPNI in determining the nutritional status and forecasting survival outcome among patients with PBC remains unclear. A total of 262 patients with PBC were retrospectively enrolled at the Second Affiliated Hospital of Kunming Medical University between January 2013 and November 2023. We used the receiver operating characteristic (ROC) curve, Kaplan-Meier survival curve, and logistic regression analysis to evaluate the predictive effects of several nutritional assessments. These assessments included the controlling nutritional status (CONUT), geriatric nutritional risk index (GNRI), prognostic nutritional index (PNI), and Cholesterol-modified Prognostic Nutritional Index (CPNI), which were evaluated for their predictive effect on the prognosis of PBC patients. In our study, after adjusting for various confounding factors, multivariate cox regression analyses revealed that CPNI (HR: 1.114, 95% CI: 1.003-1.237, P = 0.044), age (HR: 1.071, 95% CI: 1.018-1.127, P < 0.009), total bilirubin (HR:1.019, 95% CI:1.009-1.09, P < 0.001) were independent risk factors for death in patients with PBC. The Kaplan-Meier curves and ROC curves used to assess predictive accuracy showed that CPNI(0.788) had superior prognostic performance for OS compared to other nutritional indices, such as CONUT(0.724), GNRI(0.755), PNI(0.776), and UK-PBC(0.660)(P < 0.05). CPNI is superior to other nutritional scores in the prognostic assessment of PBC patients. Background Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease characterized by inflammation of the interlobular bile ducts, often associated with malabsorption of fat-soluble vitamins and osteoporosis. Thus, evaluating the nutritional status of patients with PBC and implementing appropriate interventions are significant. But CPNI in determining the nutritional status and forecasting survival outcome among patients with PBC remains unclear. Methods A total of 262 patients with PBC were retrospectively enrolled at the Second Affiliated Hospital of Kunming Medical University between January 2013 and November 2023. We used the receiver operating characteristic (ROC) curve, Kaplan-Meier survival curve, and logistic regression analysis to evaluate the predictive effects of several nutritional assessments. These assessments included the controlling nutritional status (CONUT), geriatric nutritional risk index (GNRI), prognostic nutritional index (PNI), and Cholesterol-modified Prognostic Nutritional Index (CPNI), which were evaluated for their predictive effect on the prognosis of PBC patients. Results In our study, after adjusting for various confounding factors, multivariate cox regression analyses revealed that CPNI (HR: 1.114, 95% CI: 1.003-1.237, P = 0.044), age (HR: 1.071, 95% CI: 1.018-1.127, P < 0.009), total bilirubin (HR:1.019, 95% CI:1.009-1.09, P < 0.001) were independent risk factors for death in patients with PBC. The Kaplan-Meier curves and ROC curves used to assess predictive accuracy showed that CPNI(0.788) had superior prognostic performance for OS compared to other nutritional indices, such as CONUT(0.724), GNRI(0.755), PNI(0.776), and UK-PBC(0.660)(P < 0.05). Conclusions CPNI is superior to other nutritional scores in the prognostic assessment of PBC patients. Keywords: Primary biliary cholangitis, CPNI, Prognosis Abstract Background Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease characterized by inflammation of the interlobular bile ducts, often associated with malabsorption of fat-soluble vitamins and osteoporosis. Thus, evaluating the nutritional status of patients with PBC and implementing appropriate interventions are significant. But CPNI in determining the nutritional status and forecasting survival outcome among patients with PBC remains unclear. Methods A total of 262 patients with PBC were retrospectively enrolled at the Second Affiliated Hospital of Kunming Medical University between January 2013 and November 2023. We used the receiver operating characteristic (ROC) curve, Kaplan–Meier survival curve, and logistic regression analysis to evaluate the predictive effects of several nutritional assessments. These assessments included the controlling nutritional status (CONUT), geriatric nutritional risk index (GNRI), prognostic nutritional index (PNI), and Cholesterol-modified Prognostic Nutritional Index (CPNI), which were evaluated for their predictive effect on the prognosis of PBC patients. Results In our study, after adjusting for various confounding factors, multivariate cox regression analyses revealed that CPNI (HR: 1.114, 95% CI: 1.003–1.237, P = 0.044), age (HR: 1.071, 95% CI: 1.018–1.127, P < 0.009), total bilirubin (HR:1.019, 95% CI:1.009–1.09, P < 0.001) were independent risk factors for death in patients with PBC. The Kaplan–Meier curves and ROC curves used to assess predictive accuracy showed that CPNI(0.788) had superior prognostic performance for OS compared to other nutritional indices, such as CONUT(0.724), GNRI(0.755), PNI(0.776), and UK-PBC(0.660)(P < 0.05). Conclusions CPNI is superior to other nutritional scores in the prognostic assessment of PBC patients. |
ArticleNumber | 421 |
Audience | Academic |
Author | Zhang, Lili Zheng, Mengyao Li, Wenbin Yang, Wenting Yang, Jinhui Zhu, Huiling Huang, Yaqin |
Author_xml | – sequence: 1 givenname: Huiling surname: Zhu fullname: Zhu, Huiling – sequence: 2 givenname: Mengyao surname: Zheng fullname: Zheng, Mengyao – sequence: 3 givenname: Wenbin surname: Li fullname: Li, Wenbin – sequence: 4 givenname: Yaqin surname: Huang fullname: Huang, Yaqin – sequence: 5 givenname: Lili surname: Zhang fullname: Zhang, Lili – sequence: 6 givenname: Wenting surname: Yang fullname: Yang, Wenting – sequence: 7 givenname: Jinhui surname: Yang fullname: Yang, Jinhui |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40448036$$D View this record in MEDLINE/PubMed |
BookMark | eNptkkmP1DAQhSM0iFngD3BAkbhwyeDyFueERi2WkUbiAhI3y-2lx03abuz0CG78dKoXRt0IRYqdyudXeZV32ZylnHzTvARyDaDk2wpU9bIjVHSEE2CdetJcAO-ho4x8OzvanzeXtS4JgV5R9qw554RzRZi8aH7P7vPo6-RLHrtVdjFE79p1yYuU6xRtmzZTiVPMyYxtTM7_bE1tTdrt1x5vaTrG5zGvTPnuCwJYj_jwC4tj3K4We5m0QLnars0U8Wx93jwNZqz-xWG9ar5-eP9l9qm7-_zxdnZz11kB_dTxwYY5FcIAGYhyA5XOghEBiPCCMwnMck8c55QpSkAqB8MQuJv3TsyDUeyqud3rumyW-vBlOpuod4VcFtoUdDB6LYOnwRPjPPEcBz2YoEBaJwMT3sketd7ttdab-co7iz6KGU9ET9-keK8X-UEDBSoUkajw5qBQ8o8Nzl-vYrV-xPH4vKmaUeAMJB-2zV7_gy7zpuDv2FFSCDWwI2ph0EFMIWNjuxXVN4pTCqJXAqnr_1B4Ob-KFtMVItZPDrw6dvpo8W-AEKB7wJZca_HhEQGitynV-5RqTKnepVQr9geieNuo |
Cites_doi | 10.21873/invivo.11430 10.1016/S2468-1253(19)30343-7 10.1136/flgastro-2018-101109 10.1016/j.jhep.2017.03.022 10.1080/14656566.2019.1601701 10.3390/nu14142823 10.1002/jcsm.12980 10.1016/j.mam.2007.09.009 10.1038/s41598-018-30906-8 10.1080/07853890.2019.1693056 10.32074/1591-951X-245 10.1016/j.dld.2022.12.010 10.1002/hep.1840110324 10.1016/j.cgh.2024.01.039 10.1093/ajcn/82.4.777 10.1186/s12877-020-1501-8 10.1016/S0140-6736(24)01303-5 10.3390/biomedicines10123046 10.5582/bst.2024.01108 10.1186/s12916-023-03225-7 10.3390/ijms21155357 10.17116/terarkh20178912216-225 10.3390/nu15092014 10.1155/2021/9151525 |
ContentType | Journal Article |
Copyright | 2025. The Author(s). COPYRIGHT 2025 BioMed Central Ltd. 2025. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2025 2025 |
Copyright_xml | – notice: 2025. The Author(s). – notice: COPYRIGHT 2025 BioMed Central Ltd. – notice: 2025. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2025 2025 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QP 7QR 7T5 7X7 7XB 88E 8FD 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FR3 FYUFA GHDGH H94 K9. M0S M1P P64 PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1186/s12876-025-04013-8 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Immunology Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Technology Research Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) Medical Database Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection AIDS and Cancer Research Abstracts Chemoreception Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1471-230X |
EndPage | 9 |
ExternalDocumentID | oai_doaj_org_article_6fe2fe0ade0e41869af816cd6f35ed67 PMC12125806 A842215785 40448036 10_1186_s12876_025_04013_8 |
Genre | Journal Article |
GeographicLocations | China |
GeographicLocations_xml | – name: China |
GrantInformation_xml | – fundername: the National Natural Science Foundation of China grantid: 82160106 – fundername: Second Affiliated Hospital of Kunming Medical College, China grantid: ynllT2021001, ynllT2021009 |
GroupedDBID | --- 0R~ 23N 2WC 53G 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL AAYXX ABDBF ABUWG ACGFO ACGFS ACIHN ACIWK ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK E3Z EAD EAP EAS EBD EBLON EBS EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P M~E O5R O5S OK1 OVT P2P PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS UKHRP W2D WOQ WOW XSB ALIPV CGR CUY CVF ECM EIF NPM PMFND 3V. 7QP 7QR 7T5 7XB 8FD 8FK AZQEC DWQXO FR3 H94 K9. M48 P64 PKEHL PQEST PQUKI PRINS 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c517t-49cfb255a10908d926dc1a5f105e543613c4e0d4423820168d199f4db7d5bfa83 |
IEDL.DBID | 7X7 |
ISSN | 1471-230X |
IngestDate | Wed Aug 27 01:26:03 EDT 2025 Thu Aug 21 18:36:40 EDT 2025 Fri Jul 11 17:11:05 EDT 2025 Fri Jul 25 09:29:18 EDT 2025 Tue Jun 17 21:58:53 EDT 2025 Tue Jun 17 03:41:35 EDT 2025 Tue Jun 03 01:34:04 EDT 2025 Wed Aug 20 07:45:37 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Primary biliary cholangitis Prognosis CPNI |
Language | English |
License | 2025. The Author(s). Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c517t-49cfb255a10908d926dc1a5f105e543613c4e0d4423820168d199f4db7d5bfa83 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://www.proquest.com/docview/3216558937?pq-origsite=%requestingapplication% |
PMID | 40448036 |
PQID | 3216558937 |
PQPubID | 44673 |
PageCount | 9 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_6fe2fe0ade0e41869af816cd6f35ed67 pubmedcentral_primary_oai_pubmedcentral_nih_gov_12125806 proquest_miscellaneous_3214316497 proquest_journals_3216558937 gale_infotracmisc_A842215785 gale_infotracacademiconefile_A842215785 pubmed_primary_40448036 crossref_primary_10_1186_s12876_025_04013_8 |
PublicationCentury | 2000 |
PublicationDate | 2025-05-30 |
PublicationDateYYYYMMDD | 2025-05-30 |
PublicationDate_xml | – month: 05 year: 2025 text: 2025-05-30 day: 30 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | BMC gastroenterology |
PublicationTitleAlternate | BMC Gastroenterol |
PublicationYear | 2025 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | 4013_CR2 K Chen (4013_CR14) 2024; 18 S Kushiyama (4013_CR12) 2018; 32 European Association for the Study of the Liver (4013_CR13) 2017; 67 4013_CR7 4013_CR8 L Jopson (4013_CR21) 2015; 33 AA Gossard (4013_CR26) 2019; 20 P Muratori (4013_CR18) 2008; 29 F Meyer (4013_CR23) 2020; 21 VI Reshetnyak (4013_CR20) 2022; 10 P Gentileschi (4013_CR15) 2022; 14 A Tanakai (4013_CR1) 2024; 404 SB Heymsfield (4013_CR24) 1990; 11 S Sarcognato (4013_CR19) 2021; 113 L Zheng (4013_CR5) 2024; 22 J Gazda (4013_CR3) 2021; 2021 4013_CR22 J Gazda (4013_CR6) 2023; 55 4013_CR27 S Prausmüller (4013_CR16) 2022; 13 Y Zhao (4013_CR17) 2020; 20 H Takahashi (4013_CR28) 2023; 15 L Li (4013_CR11) 2018; 8 J Shi (4013_CR10) 2023; 21 RA Shah (4013_CR25) 2020; 5 JC Goet (4013_CR4) 2019; 10 L Sun (4013_CR29) 2019; 51 O Bouillanne (4013_CR9) 2005; 82 |
References_xml | – volume: 32 start-page: 1667 year: 2018 ident: 4013_CR12 publication-title: In Vivo doi: 10.21873/invivo.11430 – volume: 5 start-page: 306 year: 2020 ident: 4013_CR25 publication-title: Lancet Gastroenterol Hepatol doi: 10.1016/S2468-1253(19)30343-7 – volume: 10 start-page: 316 year: 2019 ident: 4013_CR4 publication-title: Frontline Gastroenterol doi: 10.1136/flgastro-2018-101109 – volume: 67 start-page: 145 year: 2017 ident: 4013_CR13 publication-title: J Hepatol doi: 10.1016/j.jhep.2017.03.022 – volume: 20 start-page: 1161 year: 2019 ident: 4013_CR26 publication-title: Expert Opin Pharmacother doi: 10.1080/14656566.2019.1601701 – volume: 33 start-page: 109 issue: Suppl 2 year: 2015 ident: 4013_CR21 publication-title: Pathogenesis and Management Dig Dis – volume: 14 start-page: 2823 year: 2022 ident: 4013_CR15 publication-title: Nutrients doi: 10.3390/nu14142823 – volume: 13 start-page: 1477 year: 2022 ident: 4013_CR16 publication-title: J Cachexia Sarcopenia Muscle doi: 10.1002/jcsm.12980 – volume: 29 start-page: 96 year: 2008 ident: 4013_CR18 publication-title: Mol Aspects Med doi: 10.1016/j.mam.2007.09.009 – volume: 8 start-page: 12561 year: 2018 ident: 4013_CR11 publication-title: Sci Rep doi: 10.1038/s41598-018-30906-8 – volume: 51 start-page: 333 year: 2019 ident: 4013_CR29 publication-title: Ann Med doi: 10.1080/07853890.2019.1693056 – volume: 113 start-page: 170 year: 2021 ident: 4013_CR19 publication-title: Pathologica doi: 10.32074/1591-951X-245 – volume: 55 start-page: 1318 year: 2023 ident: 4013_CR6 publication-title: Dig Liver Dis doi: 10.1016/j.dld.2022.12.010 – volume: 11 start-page: 502 year: 1990 ident: 4013_CR24 publication-title: Hepatology doi: 10.1002/hep.1840110324 – volume: 22 start-page: 1265 year: 2024 ident: 4013_CR5 publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2024.01.039 – ident: 4013_CR7 – volume: 82 start-page: 777 year: 2005 ident: 4013_CR9 publication-title: Am J Clin Nutr doi: 10.1093/ajcn/82.4.777 – volume: 20 start-page: 107 year: 2020 ident: 4013_CR17 publication-title: BMC Geriatr doi: 10.1186/s12877-020-1501-8 – volume: 404 start-page: 1053 year: 2024 ident: 4013_CR1 publication-title: Lancet doi: 10.1016/S0140-6736(24)01303-5 – volume: 10 start-page: 3046 year: 2022 ident: 4013_CR20 publication-title: Biomedicines doi: 10.3390/biomedicines10123046 – volume: 18 start-page: 388 year: 2024 ident: 4013_CR14 publication-title: Biosci Trends doi: 10.5582/bst.2024.01108 – ident: 4013_CR27 – volume: 21 start-page: 512 year: 2023 ident: 4013_CR10 publication-title: BMC Med doi: 10.1186/s12916-023-03225-7 – volume: 21 start-page: 5357 year: 2020 ident: 4013_CR23 publication-title: Int J Mol Sci doi: 10.3390/ijms21155357 – ident: 4013_CR22 doi: 10.17116/terarkh20178912216-225 – ident: 4013_CR2 – volume: 15 start-page: 2014 year: 2023 ident: 4013_CR28 publication-title: Nutrients doi: 10.3390/nu15092014 – volume: 2021 start-page: 9151525 year: 2021 ident: 4013_CR3 publication-title: Can J Gastroenterol Hepatol doi: 10.1155/2021/9151525 – ident: 4013_CR8 |
SSID | ssj0017823 |
Score | 2.3981345 |
Snippet | Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease characterized by inflammation of the interlobular bile ducts, often associated with... Background Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease characterized by inflammation of the interlobular bile ducts, often... BackgroundPrimary biliary cholangitis (PBC) is a chronic cholestatic liver disease characterized by inflammation of the interlobular bile ducts, often... Abstract Background Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease characterized by inflammation of the interlobular bile ducts,... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 421 |
SubjectTerms | Adult Age Aged Bile ducts Bilirubin Bilirubin - blood Biomarkers - blood Blood cholesterol Breast cancer Cholangitis Cholesterol Cholesterol - blood CPNI Development and progression Female Females Health aspects Hemoglobin Hospitals Humans Kaplan-Meier Estimate Liver cirrhosis Liver Cirrhosis, Biliary - blood Liver Cirrhosis, Biliary - mortality Liver diseases Lymphocytes Malabsorption Male Malnutrition Measurement Medical prognosis Middle Aged Normal distribution Nutrition Nutrition Assessment Nutritional Status Obesity Osteoporosis Overweight Patients Primary biliary cholangitis Product/Service Evaluations Prognosis Proteins Pruritus Regression analysis Retrospective Studies Risk factors ROC Curve Serum albumin Survival Thyroid diseases Vitamins |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV0xa90wEBYhQ8lS2iZtnSbBgUCGICLbkiyNSWgIgXRqIJuQLIk-aG2IX_b89NzJ8uOZDl062VhnI-vufN_h03eEnFkmXKWtp62WgvLacqqlthQiC1dRBM4S8fzDD3n3yO-fxNNWqy-sCZvogaeFu5Qx1DEw6wMLHPsn2agq2XkZGxG8TPvIIebNyVT-fwBxr5m3yCh5OcJXuMViW0EZJhRULcJQYuv_-5u8FZSWBZNbEej2A3mfoWN5NU35I9kJ_Sfy7iH_HN8nrzfY6xaJD4bf9M_gVxHgZYkFWP2AbMxlPzPvw1MSS2Jpx9L26XxqhbveFsed-Vi88wwCcD2xUpRYS4vHlBNjr6PVWGZu1vGAPN5-_3lzR3ODBdqJql1TrrvoIKewWJ2pvK6l7yorImCuIHgDkb7jgXkOkAuBglS-0jpy71ovXLSq-Ux2-6EPX0nJnVLWN62tOgAMjiltHXbMjVK7EKQryMW83ibP2KT8Q0kzaceAdkzSjlEFuUaVbCSRAztdAMsw2TLMvyyjIOeoUIOeClrrbN5wABNGzitzpXgNgKdVoiBHC0nwsG45PJuEyR4-mqaupBCI9gpyuhnGO7FqrQ_DS5JBpgGuQebLZEGbV-IMEmOADwVRC9tavPNypF_9SvzfFcANoZg8_B-r9I3s1ckvBG3YEdldP7-EY8BZa3eSXOoN8HMofA priority: 102 providerName: Directory of Open Access Journals |
Title | Cholesterol-modified prognostic nutritional index as an independent prognostic biomarker in primary biliary cholangitis patients |
URI | https://www.ncbi.nlm.nih.gov/pubmed/40448036 https://www.proquest.com/docview/3216558937 https://www.proquest.com/docview/3214316497 https://pubmed.ncbi.nlm.nih.gov/PMC12125806 https://doaj.org/article/6fe2fe0ade0e41869af816cd6f35ed67 |
Volume | 25 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fixMxEA56B-KL-NvVs6wg-CDhsrtJNnmS63HHIdwhhwfFl5BsEi3ornZ77_7pzqRp7SL40pbNtGQ7M5lvspNvCHlrmXCVtp62WgrKa8upltpSiCxcRRE4S8Tzl1fy4oZ_XIhF3nAbc1nldk1MC7UfOtwjP27qSgqB0fXDz18Uu0bh09XcQuMuOUTqMizpahe7hKuC6NdsD8ooeTzCWtxiya2gDNMKqibBKHH2_7sy74WmadnkXhw6f0geZABZnmw0_ojcCf1jcu8yPyJ_Qn6fYsdbpD8YvtMfg19GAJkllmH1A3Iyl_2Wfx9-JXEllnYsbZ8-bxrirvfF8Xw-lvCsQACuJ26KEitq8T1lxtjxaDmWmaF1fEpuzs8-n17Q3GaBdqJq15TrLjrILCzWaCqva-m7yooIyCsI3kC873hgngPwQrggla-0jty71gsXrWqekYN-6MMLUnKnlPVNa6sOYINjSluHfXOj1C4E6Qryfvt_mzxjk7IQJc1GOwa0Y5J2jCrIHFWyk0Qm7HRhWH012bGMjKGOgVkfWODYX8tGVcnOy9iI4GVbkHeoUIP-ClrrbD52ABNG5itzongNsKdVoiBHE0nws246vDUJk_18NH-tsiBvdsP4Taxd68Nwm2SQb4BrkHm-saDdLXEG6TGAiIKoiW1N7nk60i-_JRbwCkCHUEy-_P-8XpH7dbJ4QRt2RA7Wq9vwGnDU2s2Ss8zI4fzs6tP1LO1GwOv1_MsfEGQiVw |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKKwEXxJtAgSCBOCCrediOfUCoLa22tLtCqJV6M05sw0qQwGYrxI1fxG9kxkmWjZC49bSreDZydsYz38Tjbwh5bhJepspYWijBKcsMo0ooQyGyMOm5Y0kgnp_OxOSMvTvn5xvk93AWBssqB58YHLVtKnxHvpNnqeAco-ubb98pdo3C3dWhhUZnFsfu5w9I2drXR29Bvy-y7PDgdH9C-64CtOJpsaRMVb4EIG2wJFFalQlbpYZ7ABqOsxzCW8VcYhngDIyOQtpUKc9sWVheeiNzuO8VsgWSCTiCrb2D2fsPq30LiLf5cDRHip0WvH-BRb6cJpjIUDkKf6FLwL-xYC0Yjgs11yLf4U1yo4es8W5nY7fIhqtvk6vTflP-Dvm1jz12kXCh-UK_NnbuAdbGWPhVN8gCHdcD4z_cJbAzxqaNTR2-dy14l-viyAiARUMLEIDrgQ0jxhpe_Ay5OPZYmrdxzwnb3iVnl6KCe2Szbmr3gMSslNLYvDBpBUClTKQyJXbq9UKVzokyIq-G_1v3M9Yh75FCd9rRoB0dtKNlRPZQJStJ5N4OF5rFJ90vZS28y7xLjHWJY9jRy3iZisoKn3NnRRGRl6hQjR4CtFaZ_qADTBi5tvSuZBkArULyiGyPJGFlV-PhwSR071la_XcdROTZahh_idVytWsuggwyHDAFMvc7C1o9EksgIQfYEhE5sq3RM49H6vnnwDueAszhMhEP_z-vp-Ta5HR6ok-OZsePyPUsWD-nebJNNpeLC_cYUNyyfNIvnZh8vOzV-gcGC1uU |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cholesterol-modified+prognostic+nutritional+index+as+an+independent+prognostic+biomarker+in+primary+biliary+cholangitis+patients&rft.jtitle=BMC+gastroenterology&rft.au=Zhu%2C+Huiling&rft.au=Zheng%2C+Mengyao&rft.au=Li%2C+Wenbin&rft.au=Huang%2C+Yaqin&rft.date=2025-05-30&rft.pub=BioMed+Central+Ltd&rft.issn=1471-230X&rft.eissn=1471-230X&rft.volume=25&rft.issue=1&rft_id=info:doi/10.1186%2Fs12876-025-04013-8&rft.externalDocID=A842215785 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-230X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-230X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-230X&client=summon |